XML 86 R76.htm IDEA: XBRL DOCUMENT v3.21.2
Derivative Instruments and Hedging Activities - Impact and Location of Derivative Instruments for Derivatives Designated as Cash Flow Hedging and the Related Components Excluded From Effectiveness Testing (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 30, 2021
Jul. 31, 2020
Jul. 30, 2021
Jul. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales $ 976,836 $ 840,972 $ 2,998,929 $ 2,537,853
Cost of Sales (645,719) (546,398) (1,949,823) (1,648,474)
Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain (loss) reclassified from AOCL into earnings (3,082) 1,953 (9,265) 5,970
Net Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales 976,836 840,972 2,998,929 2,537,853
Cost of Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Cost of Sales (645,719) (546,398) (1,949,823) (1,648,474)
Forward currency contracts | Net Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain (loss) reclassified from AOCL into earnings (3,113) 1,795 (9,325) 5,272
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value 322 191 784 3,183
Forward currency contracts | Cost of Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain (loss) reclassified from AOCL into earnings 31 158 60 698
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value $ 70 $ 86 $ 366 $ 231